Literature DB >> 6077419

Production of rubella hemagglutinating antigen in suspension cultures.

G L Gitnick, M M Vincent, A Auletta, A Ley, N Tzan, J L Sever.   

Abstract

Rubella virus specific hemagglutinating antigen was prepared in the fluid phase of suspension cultures. Systems employing baby hamster kidney culture adapted inocula, nonadapted inocula, and cells derived from long-term infected suspension cultures were evaluated. Optimal specific hemagglutinating titers were obtained when kaolin-treated fetal bovine serum was used in the media and when the incoulum had previously been adapted in a suspension culture system. When cultures derived from long-term infected suspension systems were studied, the number of daily harvests in which acceptable titers were present was prolonged. However, titers were generally higher in suspension systems employing cells which had recently been infected.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6077419      PMCID: PMC547174          DOI: 10.1128/am.15.5.1244-1247.1967

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Rubella virus.

Authors:  J L SEVER; G M SCHIFF; R G TRAUB
Journal:  JAMA       Date:  1962-11-10       Impact factor: 56.272

4.  Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests.

Authors:  E NORRBY
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

5.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

6.  Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

Authors:  A Vaheri; W D Sedwick; S A Plotkin; R Maes
Journal:  Virology       Date:  1965-10       Impact factor: 3.616

7.  Production of rubella complement fixing antigen in BHK-21 cells.

Authors:  K Schell; K T Wong; H C Turner; R J Huebner
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

8.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

9.  RUBELLA VIRUS: NEUTRALIZING ANTIBODY IN COMMERCIAL GAMMA GLOBULIN.

Authors:  G M SCHIFF; J L SEVER; R J HUEBNER
Journal:  Science       Date:  1963-10-04       Impact factor: 47.728

10.  Rubella virus: continuous and concurrent production of complement-fixing antigen and infectious virus in suspension cultures.

Authors:  M M Vincent; G L Gitnick; A Fabiyi; S A Hensen; J L Sever; R J Huebner
Journal:  Appl Microbiol       Date:  1967-09
  10 in total
  1 in total

1.  Influenza virus infection of the guinea pig: immune response and resistance.

Authors:  J P Phair; C A Kauffman; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.